Mor G, Yamshchikov G, Sedegah M, Takeno M, Wang R, Houghten R A, Hoffman S, Klinman D M
Section of Retroviral Immunology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
J Clin Invest. 1996 Dec 15;98(12):2700-5. doi: 10.1172/JCI119094.
Plasmid DNA vaccines capable of preventing viral, bacterial, and parasitic infections are currently under development. Our labs have shown that a plasmid DNA vaccine encoding the circumsporozoite protein of the malaria parasite elicits protective immunity against live sporozoite challenge in adult BALB/c mice. We now find that the same DNA vaccine induces tolerance rather than immunity when administered to 2-5 d-old mice. Neonatally tolerized animals were unable to mount antibody, cytokine or cytotoxic responses when rechallenged with DNA vaccine in vitro or in vivo. Tolerance was specific for immunogenic epitopes expressed by the vaccine-encoded, endogenously produced antigen. Mice challenged with exogenous circumsporozoite protein produced antibodies against a different set of epitopes, and were not tolerized. These findings demonstrate important differences in the nature and specificity of the immune response elicited by DNA vaccines versus conventional protein immunogens.
目前正在研发能够预防病毒、细菌和寄生虫感染的质粒DNA疫苗。我们实验室已表明,编码疟原虫环子孢子蛋白的质粒DNA疫苗能在成年BALB/c小鼠中引发针对活子孢子攻击的保护性免疫。我们现在发现,相同的DNA疫苗在给予2至5日龄小鼠时会诱导耐受而非免疫。新生期耐受的动物在体外或体内再次接受DNA疫苗攻击时,无法产生抗体、细胞因子或细胞毒性反应。耐受是针对疫苗编码的内源性产生抗原所表达的免疫原性表位的。用外源性环子孢子蛋白攻击的小鼠产生针对不同表位组的抗体,且未产生耐受。这些发现证明了DNA疫苗与传统蛋白质免疫原引发的免疫反应在性质和特异性上的重要差异。